Oleanolic acid, one of the major components of OleaVita, is known to be a TGR5 agonist, and oleanolic acid activates JNK via TGR5, resulting in the regulation of inflammatory cytokine production and a reduction in obesity [28,30]. Here, MAPK8 is linked to obesity due to melanocortin 4 receptor deficiency.